Inhibition of Colon Cancer Recurrence via Exogenous TRAIL Delivery Using Gel-like Coacervate Microdroplets

Colon cancer (CC) belongs to the three major malignancies with a high recurrence rate. Therefore, a novel drug delivery system that can prevent CC recurrence while minimizing side effects is needed. Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL) has recently been spotlighted as a pr...

Celý popis

Podrobná bibliografie
Hlavní autoři: Sungjun Kim, Yerim Jwa, Jiyeon Hong, Kyobum Kim
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2022-07-01
Edice:Gels
Témata:
On-line přístup:https://www.mdpi.com/2310-2861/8/7/427